Canada has unveiled a new $50-million national dementia strategy that aims to find ways to prevent brain diseases, to look for more effective treatments, and to improve services and home care for those living with dementia and their families.
Following the ‘disappointing’ announcement that two late-stage trials for a promising treatment for Alzheimer’s disease had been cancelled, a Toronto behavioural neurologist studying the drug says there’s still reason for hope.
Few seniors get their thinking and memory abilities regularly tested during check-ups, according to a new report from the Alzheimer's Association that raises questions about how best to find out if a problem is brewing.
It may be too late to stop Alzheimer's in people who already have some mental decline. But what if a treatment could target the very earliest brain changes while memory and thinking skills are still intact, in hope of preventing the disease?